Joining three teams backed by a total of $75 million, MIT researchers will tackle some of cancer’s toughest challenges.

An evolutionary biologist is studying what these resilient urban pests can teach us about adaptation and evolution.

With the new technique, MIT researchers hope to identify mutations that could be targeted with new cancer therapies.

Software allows scientists to model shapeshifting proteins in native cellular environments.

Professor Ernest Fraenkel has decoded fundamental aspects of Huntington’s disease and glioblastoma, and is now using computation to better understand amyotrophic lateral sclerosis.

A new study finds precancerous colon cells turn on a gene called SOX17, which helps them evade detection and develop into more advanced tumors.

What if plants in the area surrounding a nuclear reactor could act as radiation detectors, with the help of a drone?

MIT spinout Elicio developed a vaccine based on a lymph node-targeting approach first developed at the Koch Institute. Phase 1 solid tumor clinical trial results are promising so far.